— Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected.
— Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.
— Expects 10-12% growth in revenues for the fiscal year 2020 on a reported basis. Adjusted EPS for this period is projected in the range of $1.74 to $1.79 per share.
— BSX shares were up 0.75% immediately following the announcement.
Most Popular
Philip Morris International (PM) Earnings: 3Q20 Key Numbers
Philip Morris International Inc. (NYSE: PM) reported third quarter 2020 earnings results today. Net revenues fell 2.6% year-over-year to $7.4 billion. Revenues were down 1.5% on an organic basis. Reported
Infographic: Highlights of IBM’s (IBM) Q3 2020 earnings report
Tech giant IBM Corp. (NYSE: IBM) on Monday said its third-quarter revenues and profit declined, hurt mainly by the disruption caused by the pandemic. The top-line, however, surpassed experts' prediction,
Changes in the digital payments sector could bode well for Square (SQ) going forward
The COVID-19 pandemic and the restrictions that came with it pushed people to online transactions more than ever. This was not only due to the fact that folks who stayed